A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Moderate to Severe Active Crohn's Disease

Status:
Completed

Trial end date:
2005-11-01

Target enrollment:

Participant gender:

This is a study of infliximab (Remicade) in subjects with Crohn's disease

Phase 3

Centocor, Inc.

Infliximab